Physician profile
John Michael Cochran
NPI 1487181038
$9,750.71
in general payments reported to CMS, 2019-2025
16 companies · $2,232 in 2025
The $2,232 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.99 · 2020: $164 · 2021: $251 · 2022: $584 · 2023: $3,538 · 2024: $2,938 · 2025: $2,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,149 · Travel and Lodging: $2,173 · Grant: $779 · Education: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,148.52 |
| Travel and Lodging | $2,172.63 |
| Grant | $779.00 |
| Education | $607.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,409.14 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Selectsecure |
| Boston Scientific Corporation | $1,721.50 | 2023-2024 | S-Icd System Magnet, Watchman Flx, Mylux Patient Kit With Mobile Device |
| Abbott Laboratories | $553.07 | 2022-2024 | Ensite, Ensite Precision |
| Biosense Webster, INC. | $456.72 | 2024-2025 | Carto 3 |
| Shockwave Medical, INC | $456.41 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $258.77 | 2022-2025 | |
| Pfizer INC. | $185.32 | 2020-2022 | |
| W. L. Gore & Associates, INC. | $169.28 | 2023 | Gore Viabahn Endoprosthesis With Heparin, Gore Cardioform Septal Occluder |
| Biotronik INC. | $156.90 | 2022 | |
| Cook Incorporated | $140.85 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.80 | 2023 | Lifevest |
| Atricure, INC. | $54.48 | 2024-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.38 | 2021 | |
| Aquestive Therapeutics, INC. | $24.95 | 2019 | |
| Incyte Corporation | $19.04 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $17.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cochran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.